Sanofi is a multinational pharmaceutical company whose headquarters are currently based in Paris, France.
Their UK headquarters are at Guildford in Surrey along with a Clinical Research Unit for clinical trials across the UK and Ireland.
They are currently the world’s fourth largest pharmaceutical company based on their prescription sales. The company itself was founded in 1973 however it went on in 2004 to become Sanofi-Aventis after winning a 54.5 billion Euro bid to merge with Aventis. It is only recently that they have averted back to Sanofi in May 2011.
Aventis was a pharmaceutical and lab assay testing company, which was founded in 1999. The company’s headquarters were based in Strasbourg, France. The company also won various awards for their creation of non-literary science books for adults and children.
Sanofi currently deals with seven major areas:
- Cardiovascular
- Central Nervous System
- Diabetes
- Internal Medicines
- Oncology
- Thrombosis
- Vaccines
The company itself is comprised of over 18,000 research staff working in over 21 research and development centres, across three continents.
The company takes great pride in delivering results and this was illustrated after they spent over £4.8 billion on its portfolio in 2008.
With a expanse range of products that have been developed, they have been successful in creating ones for diabetes to. These are a couple they have manufactured:
- Insulin glulisine (Apidra) – a rapid-acting insulin for injection.
- Insulin glargine (Lantus) – a long-acting insulin intended to release over a period of 18-26 hours daily when injected.
The company has also been involved in research projects with other industrial partners such as the Innovative Medicines Initiative of the European Federation of Pharmaceutical Industries and Associations.
They have also signed contracts with universities to explore further developments of medicines and therapies.
